Acquisition to Expand Offering in Fertility Solutions and Labor & Delivery

TRUMBULL, Conn, November 11, 2021 — CooperSurgical, Inc. announced that it has signed a definitive purchase agreement to acquire Generate Life Sciences®, a privately held, leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & tissue), for approximately $1.6 billion. The transaction is anticipated to close in Cooper’s first fiscal quarter of 2022 and is subject to regulatory approval and customary closing conditions.

The planned acquisition complements CooperSurgical’s offering in both fertility solutions and labor & delivery.
“Generate’s complementary offering of donor egg and sperm as well as cryo-storage enhances our comprehensive fertility solutions portfolio and furthers our ability to empower unique journeys to starting a family,” said Holly Sheffield, President, CooperSurgical. “Additionally, advancements in regenerative medicine offer the potential for significant benefits from newborn stem cells. We are excited to enhance our focus on obstetrical health with Generate’s established leadership in cord blood and tissue storage.”

Details concerning the acquisition can be found on the Investor Relations section of Cooper’s website at http://investor.coopercos.com under the presentation titled Generate Life Sciences.

About CooperCompanies

CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

About CooperSurgical

CooperSurgical is a recognized global leader in women’s health and fertility solutions. Delivering impactful, innovative clinical products and services that advance a world with healthy women, babies and families. CooperSurgical is a wholly-owned subsidiary of CooperCompanies. CooperSurgical, headquartered in Trumbull, CT, produces and markets a wide array of products and services for use by women’s health care clinicians. More information can be found at www.coopersurgical.com.

About Generate Life Sciences

Generate Life Sciences® is a life sciences company helping to grow and protect families through reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services. We serve families from preconception to post-birth. Our brands — CBR® (Cord Blood Registry®), California Cryobank™, Donor Egg Bank USA™, NW Cryobank™, ReadyGen™, Kitazato USA™, and Donor Application™ — are pioneering leaders that have helped nearly one million families. Headquartered in Los Angeles, Generate operates facilities in Tucson, New York, Boston, Palo Alto, and Rockville, MD. Generate is a portfolio company of GI Partners, a private investment firm based in San Francisco.